Brief Communications 443 J Vet Diagn Invest 19:443 447 (2007) Light-chain multiple myeloma in a cat Osamu Yamada, Kyoichi Tamura, Hiroko Yagihara, Mayu Isotani, Mari Azakami, Satoko Sawada, Kenichiro Ono, Tsukimi Washizu, Makoto Bonkobara 1 Abstract. A diagnosis of light-chain multiple myeloma was made in an 11-year-old male American Shorthair cat. The cat showed atypical plasma cell infiltration in the bone marrow, biclonal gammopathy caused by polymerization of myeloma protein (M-protein), and Bence-Jones proteinuria. The M-protein in the serum of the cat was analyzed by using 12% sodium dodeyl sulfate (SDS) polyacrylamide gel electrophoresis with Coomassie brilliant blue staining. An intense band with a size of 27 kda, the size of the immunoglobulin light chain, was clearly observed, whereas the band corresponding to the immunoglobulin heavy chain (59 kda) was undetectable. The 27-kDa band was confirmed to be an immunoglobulin light chain by Western blotting by using antibodies for feline immunoglobulin. These data suggested that the neoplastic plasma cells produce light chain only, leading to the diagnosis of light-chain multiple myeloma in the cat. Key words: Bence-Jones protein; biclonal gammopathy; cats; immunoglobulin light chain; M-protein; multiple myeloma. <!?show "fnote_aff1"$^!"content-markup(./author-grp[1]/aff./author-grp[1]/dept-list)> From the Department of Veterinary Clinical Pathology (Yamada, Tamura, Yagihara, Isotani, Washizu, Bonkobara), and Veterinary Medical Teaching Hospital (Azakami, Sawada), Nippon Veterinary and Life Science University, Musashino-shi, Tokyo 180 8602, and the Department of Veterinary Clinical Pathobiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Ono), Bunkyo-ku, Tokyo 113-8657, Japan. 1 Corresponding Author: Makoto Bonkobara, Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180 8602, Japan. bonkobara@nvlu.ac.jp Multiple myeloma is a malignant plasma-cell dyscrasia characterized by bone-marrow plasmacytosis. Malignant plasma cells produce an abnormal monoclonal immunoglobulin; it is the most common cause of monoclonal gammopathies in humans and other animals, including dogs and cats. 4,9,12 The monoclonal immunoglobulin produced may be an entire immunoglobulin of any class, a heavy chain only, or a light chain only (light-chain multiple myeloma, also called Bence-Jones myeloma). Multiple myeloma is an uncommon neoplasm of cats and accounts for less than 1% of feline hematopoietic neoplasms. 3,7 Limited information is thus available regarding the production of immunoglobulin in feline malignant plasma cells, and myeloma producing light chain solely has not been previously reported. In this study, light-chain multiple myeloma was diagnosed in the case of a cat. An 11-year-old male American Shorthair cat was admitted to the Veterinary Medical Teaching Hospital, Nippon Veterinary and Life Science University, with anorexia, fever, and a convulsion observed the day before admission. In clinical examination, the cat was overweight (5.9 kg) and had a fever (40.0uC). On the day of presentation, complete blood cell counts (CBC), serum biochemistry, and urinalysis were performed. The CBC
444 Brief Communications Figure 1. Diagnostic findings of multiple myeloma in the cat. A, Cellulose acetate electrophoresis of serum protein. A sharp biclonal peak was identified in the c region. B and C, Bone marrow smear stained with Wright-Giemsa (4003 in B and 1,0003 in C). Atypical plasma-cell infiltration in the bone marrow was observed. Bars indicated in B and C are 20 mm and 5 mm, respectively. D, Western blotting analysis of the urine sample by using anti-feline IgG antibody (anti-igg) or sheep IgG (control IgG). Bence-Jones protein was clearly observed by anti-igg at the size of 27 kda. was normal, except for nonregenerative anemia (hematocrit, 23%; reference range, 30% 45%) and lymphopenia (835/ml; reference range, 1,500 7,000/ml), suggesting chronic disease and stress. In serum biochemistry, marked hyperproteinemia (12.9 g/dl; reference range, 5.4 7.8 g/dl) caused by hyperglobulinemia (9.5 g/dl; reference range, 2.6 5.1 g/dl) was detected. The albumin/globulin (A/G) ratio was 0.36 (reference range, 0.45 1.19). These data suggested that the cat had monoclonal or polyclonal gammopathy. To distinguish these gammopathies, serum analysis was performed by using cellulose acetate electrophoresis. Although, unexpectedly, a sharp biclonal peak was identified in the c region (Fig. 1A), the presence of biclonal gammopathy was considered to be responsible for the hyperglobulinemia. In the serum biochemistry panel of the liver, the values of alanine aminotransferase (111 U/L; reference range, 6 83 U/L), aspartate aminotransferase (785 U/L; reference range, 26 43 U/L), and alkaline phosphatase (186 U/L; reference range, 25 93 U/L) were mildly to markedly increased. The serum biochemistry panel of the kidneys was normal. Serum tests for feline immunodeficiency virus and feline infectious peritonitis virus antibodies and for feline leukemia virus antigen were negative. The urinalysis of a voided urine sample showed abnormal findings, including 3+ proteinuria and a specific gravity of 1.040, considering that glomerulopathy could be present. A bone marrow aspiration biopsy was then performed on the day of presentation because of a suspicion that the cat had multiple myeloma, because of an abnormality in the serum biochemistry, including hyperproteinemia, hyperglobulinemia, decreased A/G ratio, and a clonal peak pattern of serum electrophoresis. In the light microscopic findings of a bone marrow smear stained with Wright-Giemsa, marked plasmacytosis (.50% of bone marrow cells), with anisocytosis of the plasma cells was observed in focal regions of a slide (Fig. 1B), and other regions had moderately increased numbers of the plasma cells (approximately 20% of bone marrow cells). These plasma cells had
Brief Communications 445 flame cell morphology, characterized by peripheral pinkstained cytoplasmic processes, and displayed atypical morphology, including anisokaryosis, variable nucleus: cytoplasm (N:C) ratios, and several binucleated cells (Fig. 1C). A urine sample was thus analyzed for the detection of Bence-Jones protein with Western blotting. Urine from the cat was diluted with phosphate-buffered saline (PBS) to the protein concentration of 150 mg/ml and boiled for 5 min in 13 SDS polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. An aliquot was applied to 12% SDS-PAGE (300 ng protein/lane), transferred onto a polyvinylidene fluoride membrane, a and blotted with fluorescein isothiocyanate (FITC)-labeled sheep anti-feline immunoglobulin (Ig) G antibody, b which recognizes both heavy and light chains of feline IgG, or FITC-labeled sheep IgG (control). The fluorescent signal of the immunoreactive proteins was visualized by using the VersaDoc 5000 imaging system. c As shown in Fig. 1D, an immunoreactive single band was clearly observed at the size of 27 kda, which is the corresponding size of the immunoglobulin light chain, by an anti-feline IgG antibody, whereas, no band was observed with the control IgG, which indicated that the urine Bence-Jones protein was positive in the cat. No obvious multiple punctate lytic lesion was identified on survey skeletal radiographs. The cat s condition was then diagnosed as multiple myeloma based on the identification of clonal gammopathy, atypical plasma-cell infiltration in the bone marrow, and Bence- Jones proteinuria. The peak in the c region on electrophoresis analysis in multiple myeloma is typically single; however, some cases of multiple myeloma have been reported to have a biclonal peak in humans, as well as in cats. 1,5,11,15 Biclonal gammopathy is likely to occur by the polymerization of immunoglobulin, 1 a neoplastic transformation of a cell clone undergoing immunoglobulin class switching 8 or independent transforming events yielding proliferation of unrelated plasma cell clones. 16 To examine the possibility that the biclonal gammopathy is caused by the polymerization of produced immunoglobulin, serum of the case was analyzed by agarose gel electrophoresis under the nonreducing condition and the mildly reducing condition that dissociates polymerized immunoglobulin. Sera were diluted with PBS or PBS that contained 2-mercaptoethanol (2ME), a reducing agent, to a final concentration of 0.1 M. After sera were incubated at 37uC for 2 hr, 5-ml aliquots were electrophoresed on a 1% agarose gel, followed by staining with Coomassie brilliant blue (CBB) and densitometric tracing. A sharp biclonal peak was identified in the c region (right of the pattern; electrode side) under the nonreducing condition (Fig. 2; upper panel), whereas, one of the more cathode side peaks was integrated into a single peak at the more anode side peak (the side of albumin; + electrode side) under the reducing condition (Fig. 2; lower panel). Although some part of the second peak seems to be remaining as a shoulder peak in the reducing condition, it could reflect some incomplete dissociation of the multimers in the mildly reducing condition. Therefore, the biclonal peak found in this case was considered to represent the polymerization of immunoglobulin rather than the class Figure 2. Serum agarose gel electrophoresis under nonreducing and mildly reducing conditions. A sharp biclonal peak (indicated by arrowheads) was identified in the c region under the nonreducing condition (upper panel), whereas the biclonal peak was integrated into a single peak at the left under the reducing condition (lower panel). switching of immunoglobulin or the biclonal nature of plasma-cell clones. The myeloma protein (M-protein) was then analyzed by higher resolution electrophoresis. Sera from the patient and a normal cat were examined by 12% SDS-PAGE (300 ng protein/lane) followed by CBB staining (Fig. 3A). In contrast to normal cat serum, an intense band of 27 kda, the size of the immunoglobulin light chain, was clearly observed and the band corresponding to the immunoglobulin heavy chain (59 kda) was undetectable in the serum of the affected cat. These findings suggested that the
446 Brief Communications Figure 3. Detection of light-chain gammopathy. A, Serum protein analysis by using SDS polyacrylamide gel electrophoresis. An intense band corresponding to the immunoglobulin light chain (27 kda) was clearly detected in the serum of the affected cat, whereas it was undetectable in normal serum. The band corresponding to the immunoglobulin heavy chain (59 kda) was not detectable in affected cat serum, although it was detectable in normal serum. B, Western blotting by using anti-feline IgG antibody (anti-igg) or anti-feline immunoglobulin heavy chains (anti-igh). An intense 27-kDa band was detected in affected cat serum when compared with normal serum by anti-igg, and no detectable band was observed in the size of 59 kda by anti-igh in the affected cat serum, whereas it was detected in normal serum. malignant plasma cells produced the light chain but not the heavy chain of immunoglobulin. To confirm the 27-kDa paraprotein as an immunoglobulin light chain, Western blotting by using an antibody for feline IgG (the same antibody used for the detection of urine Bence-Jones protein) was performed after separation of serum proteins with 12% SDS-PAGE (300 ng protein/lane) (Fig. 3B; left panel). In the affected cat, an immunoreactive band of 27 kda was clearly detected that was far more intense than that in normal serum, indicating that the paraprotein in the case was a light chain of immunoglobulin. Consistent with the results of protein electrophoresis shown in Fig. 3A, no detectable band of 59 kda was observed in the affected cat serum by the same Western blotting (Fig. 3B; left panel), as well as that using feline-specific mouse monoclonal antibody for immunoglobulin heavy chain d (Fig. 3B; right panel). On the basis of these data, a diagnosis of light-chain multiple myeloma was made in the cat. The cat underwent treatment with prednisolone, but no other chemotherapy, because of deterioration of the systemic condition. The cat died 2 days after the first presentation, despite supportive therapy. Proliferation of malignant plasma cells in bone marrow might interfere with the normal production of erythrocytes, resulting in nonregenerative anemia. Elevated liver enzymes may reflect metastasis or ischemia from altered blood viscosity because of M-protein, and intense proteinuria with an increased specific gravity may indicate the presence of glomerulopathy because of light chains nephrotoxicity. These pathophysiologic abnormalities could contribute to the deterioration of systemic condition in the cat. The most common M-proteins in multiple myeloma are IgG and IgA in humans, as well as in dogs, 4,10,13 and other classes are rare. Reports of multiple myeloma that define the class of M-protein in cats have been infrequent; there are reports of IgG, IgA, and IgM, 1,6,14,17 but no previous report of light-chain multiple myeloma was found. In cases of human light-chain multiple myeloma, the detection of serum monoclonal gammopathy was relatively rare (found in 18% of patients) in spite of Bence-Jones proteinuria because of the efficient renal excretion of free light chain. 10 A case of light-chain myeloma without serum monoclonal gammopathy has been also reported in a dog. 2 In the present case, the prevention of light-chain excretion by polymerization of the chain may be associated with the existence of gammopathy in serum. Acknowledgements. This research was supported partially by a Grant-in-Aid for Scientific Research (18580323) and Academic Frontier Project for Private Universities: matching fund subsidy (2005 2009) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Sources and manufacturers a. Millipore, Bedford, MA b. American Qualex, San Clemente, CA
Brief Communications 447 c. Bio-Rad, Richmond, CA d. Serotec, Oxford, UK References 1. Bienzle D, Silverstein DC, Chaffin K: 2000, Multiple myeloma in cats: variable presentation with different immunoglobulin isotypes in two cats. Vet Pathol 37:364 369. 2. Cowgill ES, Neel JA, Ruslander D: 2004, Light-chain myeloma in a dog. J Vet Intern Med 18:119 121. 3. Eastman CA: 1996, Plasma cell tumors in a cat. Feline Pract 24:26 31. 4. Giraudel JM, Pages JP, Guelfi JF: 2002, Monoclonal gammopathies in the dog: a retrospective study of 18 cases (1986 1999) and literature review. J Am Anim Hosp Assoc 38:135 147. 5. Goranov S: 1994, Clinical aspects of biclonal myelomas. Folia Med (Plovdiv) 36:31 36. 6. Hanna F: 2005, Multiple myelomas in cats. J Feline Med Surg 7:275 287. 7. Jacobs T: 1994, Multiple myeloma in a cat with paraparesis. Feline Pract 22:28 32. 8. Kozuru M, Uike N, Takahira H, et al.: 1997, Immunoglobulin class switch from IgA1 to IgG2 and simultaneous association with Bence Jones proteinuria in the escape phase in a myeloma patient treated with interferon alpha. Br J Haematol 98:114 118. 9. Kyle RA: 1992, Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 6:347 358. 10. Kyle RA, Gertz MA, Witzig TE, et al.: 2003, Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21 33. 11. Kyle RA, Robinson RA, Katzmann JA: 1981, The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 71:999 1008. 12. MacEwen EG, Hurvitz AI: 1977, Diagnosis and management of monoclonal gammopathies. Vet Clin North Am 7:119 132. 13. Matus RE, Leifer CE, MacEwen EG, Hurvitz AI: 1986, Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 188:1288 1292. 14. McDonald WJ, Burton SA, Fuentealba IC: 1994, Plasma cell myeloma producing an immunoglobulin A paraprotein in a cat. Can Vet J 35:157. 15. Patel RT, Caceres A, French AF, McManus PM: 2005, Multiple myeloma in 16 cats: a retrospective study. Vet Clin Pathol 34:341 352. 16. Pizzolato M, Bragantini G, Bresciani P, et al.: 1998, IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism. Br J Haematol 102:503 508. 17. Williams DA, Goldschmidt MH: 1982, Hyperviscosity syndrome with IgM monoclonal gammopathy and hepatic plasmacytoid lymphosarcoma in a cat. J Small Anim Pract 23:311 323.